Scientific Director of REMEDI
The therapeutic application of adult stem cells, especially mesenchymal stem cells (MSCs) from bone marrow.
Director of REMEDI
Development of gene and cell therapy approaches to vascular disease with a special focus on the augmentation of nitric oxide bioavailability.
REMEDI Programme Manager
Kieran is responsible for coordinating and managing activities at REMEDI. This includes intellectual property management, graduate study programmes, financial management and outreach programmes.